Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03335332 · ClinicalTrials.gov registry record · NA
High Intensity Exercise for Increasing Fitness in Patients With Hypertrophic Cardiomyopathy
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT03335332 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 29 participants.
The verdict
NCT03335332, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
Although current clinical guidelines stipulate that patients with hypertrophic cardiomyopathy should not partake in high intensity exercise (HIE) or competitive sport due to safety concerns, there is no clear evidence to support this notion. In fact, two exercise training interventions in this population indicates that regular moderate to vigorous intensity exercise is efficacious for improving exercise capacity and cardiorespiratory fitness, and does not increase arrhythmia burden or adverse events. Moreover, moderate intensity exercise and HIE training significantly increases cardiorespiratory fitness in patients with cardiac disease. Such improvements are associated with substantial reductions in cardiovascular mortality and might outweigh the risk of adverse events in patients with hypertrophic cardiomyopathy (HCM). Having a genetic cardiomyopathy does not grant immunity against lifestyle related cardiometabolic diseases and inactivity is rife in HCM patients likely due to misinformation/education. It is therefore paramount to further explore the benefits of regular moderate intensity exercise and HIE in patients with HCM for proper therapeutic management of the condition.
Interventions
- BEHAVIORAL High intensity exercise
- BEHAVIORAL Moderate intensity exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2018-01-31 |
| Est. Completion | 2022-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03335332
The ClinicalTrials.gov registry entry for NCT03335332 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High intensity exercise is the first listed.
NCT03335332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03335332 about?
NCT03335332 is a clinical study titled "High Intensity Exercise for Increasing Fitness in Patients With Hypertrophic Cardiomyopathy". Although current clinical guidelines stipulate that patients with hypertrophic cardiomyopathy should not partake in high intensity exercise (HIE) or competitive sport due to safety concerns, there is no clear evidence to support this notion. In fact, two exercise training interventions in this popul...
What is the current status of trial NCT03335332?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-01-31. Estimated completion is 2022-12-20.
What interventions are being tested in trial NCT03335332?
The interventions under investigation include: High intensity exercise (BEHAVIORAL), Moderate intensity exercise (BEHAVIORAL).
Who is sponsoring clinical trial NCT03335332?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.